Filter
2743
Filtered Results: 2743
Text search:
regulatory
control
Featured
Recommendations
245
New Publications
711
Language
Document type
No document type
1262
Studies & Reports
506
Guidelines
500
Manuals
190
Strategic & Response Plan
161
Fact sheets
62
Training Material
23
Situation Updates
23
Resource Platforms
6
Brochures
5
Infographics
3
Online Courses
2
Countries / Regions
Global
126
Kenya
102
India
91
Ethiopia
58
Nigeria
56
Latin America and the Carribbean
55
Western and Central Europe
49
Sierra Leone
48
South Africa
46
Uganda
46
Ghana
44
Africa
42
Liberia
42
Zambia
37
Tanzania
34
Nepal
33
Bangladesh
32
Namibia
31
Myanmar / Burma
28
Ukraine
27
Rwanda
27
Malawi
25
West and Central Africa
24
South–East Asia Region
24
East and Southern Africa
24
Syria
21
Philippines
21
Eastern Europe
20
Lesotho
19
Middle East and North Africa
18
Paraguay
18
Zimbabwe
13
Guinea
13
Cambodia
12
Asia
12
El Salvador
11
Mozambique
11
Eastern Europe and Central Asia
11
Botswana
11
Congo, Democratic Republic of
10
Argentina
10
Eswatini/ Swaziland
10
Western Pacific Region
9
Russia
9
South Sudan
9
Indonesia
9
Senegal
8
Cameroon
7
Brazil
7
Pakistan
7
Chile
6
USA
6
North America
6
Bolivia
6
Yemen
6
Colombia
5
Burkina Faso
5
Haiti
5
Venezuela
5
Spain
5
Moldova
5
Sudan
5
Tajikistan
4
Thailand
4
Albania
4
Jordan
4
Germany
4
Georgia
4
Angola
4
Chad
4
Somalia
4
Ecuador
4
Benin
3
Laos
3
Afghanistan
3
Peru
3
Guinea-Bissau
3
United Kingdom
3
Central African Republic
3
North Macedonia
2
Timor Leste/ East Timor
2
Gambia
2
Kazakhstan
2
Iran
2
Saudi Arabia
2
Turkmenistan
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Honduras
2
Mali
2
Iraq
2
Madagascar
2
Guatemala
2
Turkey
1
Australia
1
Togo
1
China
1
Fiji
1
Kyrgyzstan
1
Niger
1
Uzbekistan
1
Burundi
1
Morocco
1
Qatar
1
Mauritania
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Sri Lanka
1
Egypt
1
Greece
1
Palestine
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
1025
Clinical Guidelines
196
Public Health
181
Key Resources
150
Women & Child Health
96
Pharmacy & Technologies
74
Capacity Building
27
Toolboxes
COVID-19
274
AMR
176
HIV
171
TB
141
Pharmacy
120
Mental Health
119
Planetary Health
113
Caregiver
91
NTDs
72
Rapid Response
65
NCDs
62
Malaria
56
Ebola & Marburg
53
Global Health Education
46
Conflict
41
Health Financing Toolbox
38
Specific Hazards
35
2.0 Rapid Response
35
Disability
31
Refugee
29
Natural Hazards
21
Zika
21
Polio
17
Cholera
11
Social Ethics
9
Interim policy guidance
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte...
The document titled "Manual for Stratifying Malaria Risk and the Elimination of Foci" by PAHO provides guidance for countries in the Americas on how to systematically assess and classify malaria transmission risk at subnational levels. It outlines a standardized approach to stratification and the id...
The COVID-19 pandemic exposed critical gaps in the global response to health crises, particularly in the financing of pandemic prevention, preparedness, response, recovery, and reconstruction. This chapter presents a comprehensive framework for pandemic financing that spans the entire pandemic cycle...
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
Preferred product characteristics and clinical development considerations
These guidelines promote the delivery of people-centred health services for STIs by providing evidence-based recommendations related to decentralization, integration, task sharing and digital health. These recommendations complement existing WHO guidelines for STI testing, treatment and management, ...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages...
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
The overall objective of this approach is to accelerate efforts toward malaria elimination by increasing
access to early diagnosis and treatment. The specific objectives are to: Minimize the barriers that the population faces in accessing timely, quality diagnosis and treatment. Reduce the time bet...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin...
Adolescents and young adults aged 10-24 remain underserved in the global response against HIV. Combination prevention, treatment and care programmes use a mix of evidence-based interventions to meet the current HIV prevention needs of adolescents and young adults. However, there needs to be a focus ...
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
The Human Resources for Health policy (HRH) will provide guidelines and the direction toward strengthening the planning, management, utilization and monitoring of health sector human resources; not forgetting responses to the contemporary challenges and developments in the sector including the mobil...
